Harrow Historical Financial Ratios
| HROWL Stock | USD 25.17 0.10 0.40% |
Harrow Health is recently reporting on over 95 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 5.64 or Days Sales Outstanding of 96.67 will help investors to properly organize and evaluate Harrow Health 8625 financial condition quickly.
Harrow |
About Harrow Financial Ratios Analysis
Harrow Health 8625Financial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Harrow Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Harrow financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Harrow Health history.
Harrow Health Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Harrow Health 8625 dividend as a percentage of Harrow Health stock price. Harrow Health 8625 dividend yield is a measure of Harrow Health stock productivity, which can be interpreted as interest rate earned on an Harrow Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Harrow Health 8625. There are two different methods for calculating Harrow Health 8625 invested capital: operating approach and financing approach. Understanding Harrow Health invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Intangibles To Total Assets
The ratio of a company's intangible assets (like goodwill and patents) to its total assets.Most ratios from Harrow Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Harrow Health 8625 current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.At this time, Harrow Health's Capex To Revenue is quite stable compared to the past year. Cash Per Share is expected to rise to 3.29 this year, although the value of PTB Ratio will most likely fall to 5.64.
| 2024 | 2025 (projected) | Dividend Yield | 6.32E-4 | 6.0E-4 | Price To Sales Ratio | 3.23 | 3.07 |
Harrow Health fundamentals Correlations
Click cells to compare fundamentals
Harrow Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Harrow Health fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 3.63 | 3.19 | 4.58 | 2.81 | 3.23 | 3.07 | |
| Ptb Ratio | 6.54 | 20.48 | 14.88 | 5.16 | 5.94 | 5.64 | |
| Days Sales Outstanding | 19.88 | 22.75 | 26.32 | 102.3 | 92.07 | 96.67 | |
| Free Cash Flow Yield | (0.0118) | (0.1) | (0.015) | (0.41) | (0.47) | (0.44) | |
| Operating Cash Flow Per Share | 0.0375 | (0.0425) | 0.19 | 0.0621 | 0.12 | 0.11 | |
| Stock Based Compensation To Revenue | 0.0568 | 0.0793 | 0.09 | 0.12 | 0.14 | 0.13 | |
| Capex To Depreciation | 0.36 | 11.9 | 2.12 | 12.36 | 11.13 | 11.68 | |
| Pb Ratio | 6.54 | 20.48 | 14.88 | 5.16 | 5.94 | 5.64 | |
| Ev To Sales | 4.03 | 3.68 | 4.66 | 3.7 | 4.26 | 4.04 | |
| Free Cash Flow Per Share | (0.035) | (0.0809) | (0.88) | (4.56) | (4.1) | (3.9) | |
| Roic | (0.0316) | (0.003209) | (0.0127) | 0.001683 | 0.001515 | 0.001591 | |
| Inventory Turnover | 5.07 | 3.65 | 4.32 | 3.88 | 4.19 | 5.23 | |
| Net Income Per Share | (0.1) | (0.13) | (0.67) | (0.51) | (0.75) | (0.71) | |
| Days Of Inventory On Hand | 99.99 | 84.51 | 94.06 | 100.06 | 115.07 | 92.81 | |
| Payables Turnover | 3.97 | 3.52 | 3.94 | 1.85 | 1.67 | 2.24 | |
| Research And Ddevelopement To Revenue | 0.0494 | 0.15 | 0.0344 | 0.0511 | 0.0588 | 0.0558 | |
| Capex To Revenue | 0.0203 | 0.39 | 0.0877 | 1.17 | 1.35 | 1.41 | |
| Cash Per Share | 1.26 | 1.89 | 3.71 | 2.54 | 2.92 | 3.29 | |
| Pocfratio | (161.49) | 45.49 | 237.73 | 95.13 | 85.62 | 89.9 | |
| Interest Coverage | (0.73) | (0.0522) | (0.24) | 0.0202 | 0.0182 | 0.0191 | |
| Capex To Operating Cash Flow | (0.9) | 5.61 | 4.56 | 39.73 | 35.75 | 37.54 | |
| Pfcf Ratio | (84.83) | (9.87) | (66.8) | (2.46) | (2.21) | (2.32) | |
| Days Payables Outstanding | 91.99 | 103.68 | 92.61 | 197.27 | 226.86 | 169.86 | |
| Income Quality | 0.32 | (0.28) | (0.12) | (0.16) | (0.18) | (0.17) | |
| Roe | (0.13) | (1.6) | (0.52) | (0.34) | (0.31) | (0.33) | |
| Ev To Operating Cash Flow | (179.16) | 52.53 | 242.36 | 125.45 | 112.9 | 118.55 | |
| Pe Ratio | (51.96) | (12.84) | (28.77) | (14.96) | (13.47) | (14.14) | |
| Return On Tangible Assets | (0.0459) | (0.0619) | (0.22) | (0.11) | (0.16) | (0.15) | |
| Ev To Free Cash Flow | (94.11) | (11.39) | (68.1) | (3.24) | (2.92) | (3.06) | |
| Earnings Yield | (0.0192) | (0.0779) | (0.0348) | (0.0668) | (0.0601) | (0.0631) | |
| Intangibles To Total Assets | 0.0395 | 0.18 | 0.17 | 0.52 | 0.47 | 0.49 | |
| Net Debt To E B I T D A | 5.57 | (3.53) | (2.47) | 11.97 | 10.78 | 11.31 | |
| Current Ratio | 3.72 | 6.24 | 6.35 | 2.83 | 3.25 | 5.9 | |
| Tangible Book Value Per Share | 0.95 | (0.24) | 0.0261 | (2.82) | (3.24) | (3.08) | |
| Receivables Turnover | 18.36 | 16.04 | 13.87 | 3.57 | 4.1 | 3.9 | |
| Graham Number | 1.77 | 2.53 | 3.38 | 6.04 | 6.95 | 6.6 | |
| Shareholders Equity Per Share | 1.05 | 0.42 | 0.99 | 2.17 | 2.5 | 2.13 | |
| Debt To Equity | 0.87 | 6.91 | 3.82 | 2.69 | 2.42 | 2.54 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.